Bilaterally three-dimensional scanned arms to assess the viability of early three-dimensional printing in fracture care: A cross-sectional study
Journal of Sports and Rehabilitation Sciences · 2025
DOI: 10.32598/jsrs.2411.1024 ↗Abstract
Three-dimensional (3-D) printing casting is a promising opportunity for improving patient experience and reducing complications associated with fracture management. One of the significant drawbacks of this method is the time and cost required to produce a 3-D printed cast. This study investigates whether 3-D printing below elbow upper limb casts can be streamlined by commencing the scanning stage at the initial visit rather than waiting for swelling to come down. In this cross-sectional study, the Artec Eva 3-D scanner was used to scan both arms in uninjured participants. We then measured and assessed the discrepancy between the right and left arm dimensions at standardized points from a reference identified using anatomical landmarks. The results were processed using the Artec 17 software to output data, and we subsequently discussed whether we could use a 3-D scan of the contralateral arm to design a 3-D-printed cast at the time of initial fracture presentation. Thirty-nine consented participants who met the inclusion criteria were scanned, and the results were processed. Perimeter, area data, and net and absolute variances were calculated for each participant. A simple agreement analysis compared the right and left perimeter data. The overall average concordance correlation coefficient for perimeter data was 0.92. The Absolute Mean difference in area between the right and left arm was 5.67%, and the mean absolute perimeter variance was 3.29%. Meanwhile, 3-D printed casts remain a promising prospect in fracture management. Following statistical analysis, we concluded that our study method would not be recommended to streamline the 3-D printing process. Therefore, more technological development and research are needed to produce a more cost- and time-effective method that is safe for widespread clinical use.
EUVIMED